IP Library › Granted Patent US 10,144,793
Granted Patent B2
US 10,144,793 · App. 15/910,976 · Granted Dec 4, 2018

Polymer particles

Inventors: Gregory M. Cruise (Rancho Santa Margarita, CA); Gloria Hincapie (Aliso Viejo, CA); Clayton Harris (Aliso Viejo, CA)
Assignee: Terumo Corporation
C08F220/38A61K9/0029A61K9/1635A61L24/001A61L24/06A61L31/048C08F220/56A61L2430/36C08F222/1006C08F222/385C08F2220/382C08F2222/408Y10T428/2982
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,144,793
App. No.
15/910,976
Granted
Dec 4, 2018
Kind
B2
Abstract

Biodegradable, cross-linked polymer particle embolics and methods of making the same are described. The particle embolics can be used as embolization agents.

Claims (24)

1. A polymer particle comprising:

a reaction product of a prepolymer solution including at least one monomer including at least one functional group; and

at least one crosslinker selected from bis-glycidyl amino alcohol, bi-functionalized methacryloyl-Ala-Pro-Gly-Leu-AEE-methacrylate,

wherein a, b, c, d, e, and f are each independently 1-20;

wherein the polymer particle is susceptible to degradation through hydrolysis or enzymatic action.

2. The polymer particle of claim 1 , wherein the polymer particle has a diameter between about 40 μm and about 1,200 μm.

3. The polymer particle of claim 1 , wherein the polymer particle has a diameter between about 75 μm and about 1,200 μm.

4. The polymer particle of claim 1 , wherein the polymer particle has a diameter between about 50 μm and about 1,500 μm.

5. The polymer particle of claim 1 , wherein the polymer particle has a diameter between about 100 μm and about 1,000 μm.

6. The polymer particle of claim 1 , wherein the polymer particle has a diameter between about 40 μm and about 60 μm.

7. The polymer particle of claim 1 , wherein the at least one functional group is acrylate, acrylamide, methacrylate, or methacrylamide.

8. The polymer particle of claim 1 , wherein the at least one monomer includes an ionizable functional group.

9. The polymer particle of claim 8 , wherein the ionizable functional group is basic or acidic.

10. The polymer particle of claim 1 , including a second crosslinker including a second linkage selected from an ester, a thioester, a carbonate, a peptide cleavable by matrix metalloproteinases, a peptide cleavable by matrix collagenases, a peptide cleavable by matrix elastases, and a peptide cleavable by matrix cathepsins.

11. The polymer particle of claim 1 , wherein the polymer particle is biodegradable.

12. The polymer particle of claim 1 , wherein the polymer particle is substantially degraded within about 1 months of implantation.

13. The polymer particle of claim 1 , wherein the at least one monomer is dimethylacrylamide and the at least one crosslinker is bis-glycidyl amino alcohol.

14. The polymer particle of claim 1 , wherein the at least one monomer is acrylamide and the at least one crosslinker is bi-functionalized methacryloyl-Ala-Pro-Gly-Leu-AEE-methacrylate.

15. The polymer particle of claim 1 having a fraction of circularity of greater than about 0.8.

16. The polymer particle of claim 1 having a fraction of circularity of greater than about 0.9.

17. The polymer particle of claim 1 , wherein the degradation is in less than about 1 month.

18. The polymer particle of claim 1 , wherein the degradation is in less than about 6 months.

19. The polymer particle of claim 1 , further including a dye.

20. The polymer particle of claim 19 , wherein the dye is reactive blue 21, reactive orange 78, reactive yellow 15, reactive blue No. 19, reactive blue No. 4, C.I. reactive red 11, C.I. reactive yellow 86, C.I. reactive blue 163, C.I. reactive red 180, C.I. reactive black 5, C.I. reactive orange 78, C.I. reactive yellow 15, C.I. reactive blue No. 19, C.I. reactive blue 21, or a combination thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2018
From: CRUISE, GREGORY M.; HINCAPIE, GLORIA; HARRIS, CLAYTON
To: MICROVENTION, INC.
Reel/Frame 045094/0792 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2018
From: MICROVENTION, INC.
To: TERUMO CORPORATION
Reel/Frame 045094/0824 →
Continuity (5)
Continuation 15630048 · Jun 22, 2017
Continuation 15369213 · Dec 5, 2016
Continuation 14491776 · Sep 19, 2014
Provisional Application 61880036 · Sep 19, 2013
Related Publication 20180186915A1 · Jul 5, 2018
Cited By (2)
US 12,364,786 US 12,447,228